Glutamine appears to be an important factor for intensified OXPHOS, as treatment of BCR/ABL positive CML cell lines with a glutaminase inhibitor drastically hampered OXPHOS [361]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.